Electrical and Magnetic Neurostimulation
Applications, Technologies, and Market Potential
| Publication Date | September 2004 |
|---|---|
| Publisher | Kalorama Information |
| Product Type | Report |
| Pages | 179 |
| ISBN Number | not applicable |
| Product Code | KAL00046 |
Summary
Neural and muscular stimulation by electronic and magnetic means have evolved into a burgeoning product development and commercial fields. For decades, transcutaneous electronic nerve stimulation (TENS) has been a mainstay in the pain relief arsenal. Through the years, as biocompatibility problems were being solved, electrode and sensor implants developed into a multitude of technologies with healthcare applications.
The growing approval of these applications by government regulators and the growing acceptance by insurance carriers have driven the market. These techniques have piqued the imagination of many alternative medicine advocates and clients, creating a market for products that need not pass the regulator's tests. As neural stimulation devices have become smaller (many the size of handheld calculators), less expensive (dual channel TENS units for less than a hundred dollars), and less complicated to operate, the segment has filled with products that are relatively easy to market.
However, modern science and microelectronics manufacturing capabilities promise a future marketplace filled sophisticated devices and applications as well. These exciting innovations are now evolving from the integration of new technologies like wireless communications and sensors, MEMS and nanoelectronics, digital signal processing, advances in biocompatibility, and the development of nerve-to-electronics interfaces. Cochlear implants are enabling deaf to hear, neural prosthetics are aiding atrophied muscles to move, and other miracles are in the offing.
Content
- Chapter One: Executive Summary
- Electrostimulation and Neuroprosthetic Technology Introduction
- Scope of This Report
- A Strong Market Foundation
- Future Directions
- Chapter Two: Survey Of Electrostimulation And Neuroprosthetics
- Stimulation Therapeutics for Muscles and Nerves
- Medical Applications of External Electrode Modalities
- Electrical Stimulation by External Electrode
- External Electrodes for Measurement and Diagnosis
- Stimulation by Magnetic Field Pulses
- Ultrasonic and Short Wavelength Diathermy
- Medical Applications of Implanted Electrode Modalities
- Spinal Cord Stimulation
- Characteristics of the Electrostimulation Market
- Market Segmentation of Neurostimulation Modalities
- Market Projections, Trends, and Assumptions
- Competitors in Electrostimulation Markets
- Applicable Industrial and Regulatory Codes
- Companies in the Electrostimulation Market
- Neurostimulation for Depression
- The Neuron-Silicon Interface
- Uncertainties in Electrostimulation Business Development Management
- Chapter Three: Electrostimulation With External
- ELECTRODES
- Therapeutic Applications of Electrostimulation
- Introduction
- EMS, NMS, TENS
- Variants of EMS Procedures
- Other Types of Stimulators
- Physiology of EMS Applications
- Endurance Training by Increased Oxygen Supply
- Muscle Recovery via Increased Blood Flow
- Muscle Diagnostics with Electromyography
- Transcutaneous Electrical Nerve Stimulation (TENS)
- Early Observations of Pain Relief
- Physiological Model Theories
- Interferential Current
- Galvanic Stimulation
- Electrodes
- Unit Costs and Market Size
- Market Forecasts for Electrostimulation With External Electrodes
- Bone Growth Stimulation
- Ultrasound-Accelerated Fracture Healing
- Chapter Four: Electrostimulation And Neuromodulation With Implanted Electrodes
- Introduction
- Types of Implanted Electrode Systems
- Spinal Cord Stimulation (SCS)
- Basic Implementation
- SCS vs TENS in Pain Relief
- Cost-Benefit Analysis of SCS
- Sacral Nerve Stimulation (SNS)
- Control of Urinary Incontinence
- Control of Fecal Incontinence
- Vagus Nerve Stimulation (VNS)
- Seizure Control in Epilepsy
- Treatment of Depression
- Deep Brain Stimulation (DBS)
- Treatment of Neurological Movement Disorders
- Market Forecasts for Electrostimulation With Implanted Electrodes
- Electrophrenic Pacemaker
- Gastric Electrical Stimulation (GES)
- Neuroprosthetics
- Functional Electrical Stimulation (FES)
- Cochlear Implants
- Ocular Implants
- Chapter Five: Neurostimulation With Magnetic Fields
- Introduction
- Transcranial Magnetic Stimulation (TMS)
- Depression Treatment
- Neurological Trauma Therapy
- Auditory Hallucinations
- Effects on Cerebral Blood Flow
- Magnetic Therapy Market Forecasts
- TMS/rTMS Instrument Parameters
- Chapter Six: Company Profiles, Products, And Strategies
- Acumed Medical Supplies
- Adaptive Technology Resource Centre (University of Toronto)
- Advanced Neuromodulation Systems (ANS)/ Hi-Tronics Designs, Inc. (HDI)
- American Imex
- Amrex Electrotherapy Equipment (Division of Amrex-Zetron)
- Austin Medical Equipment
- Banner Therapy Products
- BioMedical Life Systems
- Chattanooga Group
- Compex
- CONMED Corporation
- CPR Medical
- Cyberonics
- Delsys
- Dynatronics
- DynaWave
- Electromedical Products International (EPI)
- EME Services
- Empi
- Exogen/Smith & Nephew
- Hill Laboratories
- International Medical Electronics
- Koalaty Products
- LSI International
- Magstim
- MedFaxx
- Medtronic (Medtronic Neurological)
- Medical Services Company (MSC)
- NESS Ltd.
- NeuMed
- Neuronetics
- NeuroTech
- Newcare Products
- Noraxon
- Northstar Neuroscience
- OrthoLogic
- Pharmaceutical Innovations, Inc. (PII)
- Prizm Medical
- Quality Health Products (QHP)
- Rehabilicare
- Rich-Mar
- RS Medical
- Sparta Surgical
- Somatics, LLC
- Thought Technology Ltd.
- Vertis Neuroscience
- Williams Healthcare Systems
- Appendix A: Company Directory
- Appendix B: Patents On Neurostimulation And Medical Electrodes
- Assignees for U.S. Patents Issued in the Past Year
- Abstracts of Recent Applicable Patents
- List Of Exhibits
- Chapter Two: Survey Of Electrostimulation And Neuroprosthetics
- Exhibit 2-1: Energy/Radiation Stimulation Medical Electronics Products
- Exhibit 2-2: Implanted Electrode Stimulation Technologies
- Exhibit 2-3: North American Market for Electrostimulation Devices (Implanted and External Electrodes) Revenues and CAGRs 2003-2008
- Exhibit 2-4: Market Drivers Impacting Electrostimulation Equipment Sales
- Exhibit 2-5: Market Restraints Limiting Electrostimulation Equipment Sales
- Exhibit 2-6: Standard Industrial Codes (SIC) for Electrical/Magnetic Stimulation Equipment
- Exhibit 2-7: North American Industry Classification System (NAICS) Codes for Electrical/Magnetic Stimulation Equipment
- Exhibit 2-8: Major Electrostimulation Equipment Companies 2003/2004
- Chapter Three: Electrostimulation With External Electrodes
- Exhibit 3-1: TENS and EMS Stimulation Modes
- Exhibit 3-2: Electrode Stimulation Modalities with External Electrodes Type and Description
- Exhibit 3-3: EMS/NMS Device
- Exhibit 3-4: TENS Device
- Exhibit 3-5: Advanced TENS System
- Exhibit 3-6: Microcurrent TENS Unit
- Exhibit 3-7: Interferential TENS Unit
- Exhibit 3-8: Galvanic (High Voltage, DC) Stimulator
- Exhibit 3-9: North American Market for External Electrode Electrostimulation Devices (TENS and EMS) Revenues and CAGRs 2003-2008
- Chapter Four: Electrostimulation And Neuromodulation With Implanted Electrodes
- Exhibit 4-1: North American Market for Implanted Electrode Electrostimulation Devices (SNS, VNS, DBS, SCS, and Other) Revenues and CAGRs 2003-2008
- Exhibit 4-2: North American Market for FES Devices Revenues and CAGRs 2003-2008
- Exhibit 4-3: North American Market for Cochlear Implants Revenues and CAGRs 2003-2008
- Exhibit 4-4: North American Market for Ocular Implants Revenues and CAGRs 2004-2008
- Chapter Five: Neurostimulation With Magnetic Fields
- Exhibit 5-1: North American Market for Magnetic Stimulation (TMS and ECT) Revenues and CAGRs 2003-2008
About this Product
Delivery Details
PDF:Delivered by email within 12 to 24 hours of placing the order (Mon-Fri)
PRINT/CD-ROM:Despatched within 2 to 4 working days.
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















